# CHIMERA-Bench: A Benchmark Dataset for Epitope-Specific Antibody Design

arXiv: https://arxiv.org/abs/2603.13431 · HTML: https://mlsanity.com/paper/2603.13431/

## Key facts

- Cited by 4 papers in the map (data through 14 Oct 2026).
- Builds on 14 of its 44 references that are in the map.
- First posted on arXiv 13 Mar 2026.

## Builds on (most cited first, 14 of 14)

- [Iterative Refinement Graph Neural Network for Antibody Sequence-Structure Co-design](https://mlsanity.com/paper/2110.04624/) (2021)
- [Conditional Antibody Design as 3D Equivariant Graph Translation](https://mlsanity.com/paper/2208.06073/) (2022)
- [ATOM3D: Tasks On Molecules in Three Dimensions](https://mlsanity.com/paper/2012.04035/) (2020)
- [End-to-End Full-Atom Antibody Design](https://mlsanity.com/paper/2302.00203/) (2023)
- [AbDiffuser: Full-Atom Generation of in vitro Functioning Antibodies](https://mlsanity.com/paper/2308.05027/) (2023)
- [AbODE: Ab Initio Antibody Design using Conjoined ODEs](https://mlsanity.com/paper/2306.01005/) (2023)
- [dyAb: Flow Matching for Flexible Antibody Design with AlphaFold-driven Pre-binding Antigen](https://mlsanity.com/paper/2503.01910/) (2025)
- [Retrieval Augmented Diffusion Model for Structure-informed Antibody Design and Optimization](https://mlsanity.com/paper/2410.15040/) (2024)
- [Antibody Design and Optimization with Multi-scale Equivariant Graph Diffusion Models for Accurate Complex Antigen Binding](https://mlsanity.com/paper/2506.20957/) (2025)
- [AsEP: Benchmarking Deep Learning Methods for Antibody-specific Epitope Prediction](https://mlsanity.com/paper/2407.18184/) (2024)
- [Relation-Aware Equivariant Graph Networks for Epitope-Unknown Antibody Design and Specificity Optimization](https://mlsanity.com/paper/2501.00013/) (2024)
- [AbFlowNet: Optimizing Antibody-Antigen Binding Energy via Diffusion-GFlowNet Fusion](https://mlsanity.com/paper/2505.12358/) (2025)
- [AbBiBench: A Benchmark for Antibody Binding Affinity Maturation and Design](https://mlsanity.com/paper/2506.04235/) (2025)
- [Generative Co-Design of Antibody Sequences and Structures via Black-Box Guidance in a Shared Latent Space](https://mlsanity.com/paper/2508.11424/) (2025)

## Built on by (most cited first, 4 of 4)

- [EvoStruct: Bridging Evolutionary and Structural Priors for Antibody CDR Design via Protein Language Model Adaptation](https://mlsanity.com/paper/2605.21485/) (2026)
- [ConTact: Contact-First Antibody CDR Design via Explicit Interface Reasoning](https://mlsanity.com/paper/2605.21600/) (2026)
- [AgForce Enables Antigen-conditioned Generative Antibody Design](https://mlsanity.com/paper/2605.21610/) (2026)
- [EpiBench: Can LLMs Understand Epitopes for Antibody Drug Discovery?](https://mlsanity.com/paper/2608.06022/) (2026)

## Abstract (arXiv)

Computational antibody design has seen rapid methodological progress, with dozens of deep generative methods proposed in the past three years, yet the field lacks a standardized benchmark for fair comparison and model development. These methods are evaluated on different SAbDab snapshots, non-overlapping test sets, and incompatible metrics, and the literature fragments the design problem into numerous sub-tasks with no common definition. We introduce CHIMERA-Bench: (CDR Modeling with Epitope-guided Redesign), a unified benchmark built around a single canonical task: epitope-conditioned CDR sequence-structure co-design. CHIMERA-Bench provides three components. The first is a curated, deduplicated dataset of 2,922 antibody-antigen complexes with epitope and paratope annotations. The second is a set of three biologically motivated splits that test generalization to unseen epitopes, unseen antigen folds, and prospective temporal targets. The third is a comprehensive evaluation protocol with five metric groups, including novel epitope-specificity measures. We benchmark eleven methods spanning six generative paradigms and report results across all splits. CHIMERA-Bench is the largest dataset of its kind for the antibody design problem, allowing the community to develop and test novel methods and evaluate their generalizability.
